Vaccination as personal public-good provision
How to cite
Reddinger, Lucas; Charness, Gary; Levine, David. 2021. "Vaccination as personal public-good provision." AEA RCT Registry. AEARCTR-0008216. https://doi.org/10.1257/rct.8216-2.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
Vaccination against infectious diseases has both private and public
benefits. We study whether social preferences---concerns for the
well-being of other people---are associated with one's decision
regarding vaccination. We measure these social preferences for 549
online subjects with a public-good game and an altruism game. To the
extent that one gets vaccinated out of concern for the health of others,
contribution in the public-good game is analogous to an individual's
decision to obtain vaccination, while our altruism game provides a
different measure of altruism, equity, and efficiency concerns. We proxy
vaccine demand with how quickly a representative individual voluntarily
took the initial vaccination for COVID-19 (after the vaccine was widely
available). We collect COVID-19 vaccination history separately from the
games to avoid experimenter-demand effects. We find a strong result:
Contribution in the public-good game is associated with greater demand
to voluntarily receive a first dose, and thus also to vaccinate earlier.
Compared to a subject who contributes nothing, one who contributes the
maximum ($4) is 58% more likely to obtain a first dose voluntarily in
the four-month period that we study (April through August 2021). In
short, people who are more pro-social are more likely to take a
voluntary COVID-19 vaccination. Behavior in our altruism game does not
predict vaccination. We recommend further research on the use of
pro-social preferences to help motivate individuals to vaccinate for
other transmissible diseases, such as the flu and HPV.
Experimental design
We registered our study “Can targeted messages reduce COVID-19 vaccination hesitancy?” as AEARCTR-0007478 and conducted the trial in April 2021. In August 2021 we followed a sample of these respondents to collect additional participant characteristics.
We sought to attain a follow-up sample balanced between those reporting that they had taken a COVID-19 vaccine dose and those reporting that they had not. To this end, we randomly sampled half of participants who in April said that they intended to take a vaccine dose as soon as possible; we randomly sampled half of participants who were not classified as being a member of any segment of interest; we sampled the entirety of all other subjects. This provided a sample of 2441 participants from the 3668 qualified participants in April.
Of the multitude of characteristics we solicited from participants in August, we have only analyzed one. We tabulated whether (and when) respondents reported having taken a vaccine dose. Our results:
Have you taken a COVID-19 vaccine dose?
No 336 (56%)
Yes, in... 262 (44%)
April 86 (14%)
May 77 (13%)
June 41 (7%)
July 35 (6%)
August 18 (3%)
Unsure 4 (1%)
Prefer not to say 4 (1%)
We have thus achieved a sample well-balanced on our primary characteristic of interest.
We now will follow these participants yet again in an incentivized online session titled “Survey with decision-making for bonus payment.” This session will be run under a different survey account than previous sessions to eliminate any possible framing effects. Each participant is given $4 to play a variety of games that relate to pro-social preferences. We include two games to check participant comprehension. Our regression analyses will include the covariates collected in August. We will test whether pro-social behavior in our incentivized games predicts self-reported vaccination.
Design details
Materials
Papers from this trial
- Reddinger, J. L., Gary Charness, and David Levine. 2024. "Vaccination as personal public-good provision." Journal of Economic Behavior & Organization 224 (August) 481--499. https://doi.org/10.1016/j.jebo.2024.06.015
Cited by
No citation data available for this registration yet.